Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.
Hillengass J et al. Blood Cancer J. 2017 Aug 25;7(8):e599. doi: 10.1038/bcj.2017.78.

High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma.
Mills JR et al. Blood Cancer J. 2017 Aug 25;7(8):e590. doi: 10.1038/bcj.2017.75.

Evaluation of pretreatment red cell distribution width in patients with multiple myeloma.
Wang J et al. Cancer Biomark. 2017 Aug 11. doi: 10.3233/CBM-170032. [Epub ahead of print].

Multiple Myeloma and Dual-Energy CT: Diagnostic Accuracy of Virtual Noncalcium Technique for Detection of Bone Marrow Infiltration of the Spine and Pelvis.
Kosmala A et al. Radiology. 2017 Aug 11:170281. doi: 10.1148/radiol.2017170281. [Epub ahead of print].

Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis.
Ntellas P et al. Acta Haematol. 2017 Aug 11;138(2):77-84. doi: 10.1159/000478085. [Epub ahead of print].

IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma.
Kasamatsu T et al. Hematol Oncol. 2017 Aug 7. doi: 10.1002/hon.2469. [Epub ahead of print].

Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.
Jung SH et al. Haematologica. 2017 Aug 3. pii: haematol.2017.168070. doi: 10.3324/haematol.2017.168070. [Epub ahead of print].

Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM et al. Clin Chem Lab Med. 2017 Aug 3. pii: /j/cclm.ahead-of-print/cclm-2017-0339/cclm-2017-0339.xml. doi: 10.1515/cclm-2017-0339. [Epub ahead of print].

Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.
Terpos E et al. Ann Hematol. 2017 Aug 1. doi: 10.1007/s00277-017-3078-7. [Epub ahead of print].

Rapid Onset of B12 Deficiency in the Setting of Worsening Multiple Myeloma: Correlations between B12 Deficiency and Multiple Myeloma.
Seegobin K. et al. Case Rep Oncol Med. 2017;2017:6458676. doi: 10.1155/2017/6458676. Epub 2017 Jul 31.